WARSAW— Depression is the most common form of mental illness in the United States. One in three patients suffers from treatment-resistant depression (TRD), which is depression that doesn’t improve after the administration of at least two different antidepressant therapies. A new drug called esketamine, approved by the FDA in March is showing great promise in …read more.